Financial Snapshot: Analyzing Summit Therapeutics Inc (SMMT)’s Key Ratio Metrics

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

The closing price of Summit Therapeutics Inc (NASDAQ: SMMT) was $4.68 for the day, down -2.40% from the previous closing price of $4.80. In other words, the price has decreased by -$2.40 from its previous closing price. On the day, 1.67 million shares were traded. SMMT stock price reached its highest trading level at $5.12 during the session, while it also had its lowest trading level at $4.68.


Our analysis of SMMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.97 and its Current Ratio is at 6.97. In the meantime, Its Debt-to-Equity ratio is 2.48 whereas as Long-Term Debt/Eq ratio is at 2.39.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May 07, 2024, initiated with a Buy rating and assigned the stock a target price of $7.

On March 26, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $8.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.

Zanganeh Mahkam bought 26,000 shares of SMMT for $96,720 on Mar 27 ’24. The Chief Executive Officer now owns 520,814 shares after completing the transaction at $3.72 per share. On Mar 26 ’24, another insider, Dhingra Ankur, who serves as the Chief Financial Officer of the company, bought 100,000 shares for $3.75 each. As a result, the insider paid 375,000 and bolstered with 354,958 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 3369503488 and an Enterprise Value of 3241616384.

Stock Price History:

Over the past 52 weeks, SMMT has reached a high of $5.39, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is 14.69%, while the 200-Day Moving Average is calculated to be 61.90%.

Shares Statistics:

SMMT traded an average of 2.29M shares per day over the past three months and 2698210 shares per day over the past ten days. A total of 701.66M shares are outstanding, with a floating share count of 83.02M. Insiders hold about 88.17% of the company’s shares, while institutions hold 6.06% stake in the company. Shares short for SMMT as of 1714435200 were 23396445 with a Short Ratio of 10.22, compared to 1711584000 on 21805380. Therefore, it implies a Short% of Shares Outstanding of 23396445 and a Short% of Float of 28.07.

Most Popular

[the_ad id="945"]